SPRI | Hereditary Breast And Ovarian Cancer: Molecular Mechanism And Clinical Practice (2021 EN)

Discussion in 'Medicine' started by Kanka, Dec 13, 2021.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Seigo Nakamura (Editor), Daisuke Aoki (Editor), Yoshio Miki (Editor)
    Full Title: Hereditary Breast And Ovarian Cancer: Molecular Mechanism And Clinical Practice
    Publisher: Springer; 1st ed. 2021 edition (October 21, 2021)
    Year: 2021
    ISBN-13: 9789811645211 (978-981-16-4521-1), 9789811645204 (978-981-16-4520-4), 9789811645235 (978-981-16-4523-5)
    ISBN-10: 9811645213, 9811645205, 981164523X
    Pages: 324
    Language: English
    Genre: Medicine: Oncology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 160.49 €


    This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease.

    Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.


    Overview:
    ✓ Discusses the molecular mechanisms, genetic testing and counseling, and variants of unknown significance
    ✓ Includes a special chapter on the recent findings from the HBOC database, ethical issues and the parp inhibitors
    ✓ Appeals to breast surgeons, medical oncologists, gynecological oncologists and genetic counselors

    -------------